These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 6132698

  • 41. Diazepam-cimetidine drug interaction: a clinically significant effect.
    Ruffalo RL, Thompson JF, Segal JL.
    South Med J; 1981 Sep; 74(9):1075-8. PubMed ID: 6116285
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Propranolol interactions with diazepam, lorazepam, and alprazolam.
    Ochs HR, Greenblatt DJ, Verburg-Ochs B.
    Clin Pharmacol Ther; 1984 Oct; 36(4):451-5. PubMed ID: 6434219
    [Abstract] [Full Text] [Related]

  • 45. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
    Oelkers W, Foidart JM, Dombrovicz N, Welter A, Heithecker R.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
    [Abstract] [Full Text] [Related]

  • 46. The third S.K. & F. Prize lecture, University of London, December 1981. The clinical pharmacology of oral contraceptive steroids.
    Orme ML.
    Br J Clin Pharmacol; 1982 Jul; 14(1):31-42. PubMed ID: 7049209
    [Abstract] [Full Text] [Related]

  • 47. Ranitidine does not impair oxidative or conjugative metabolism: noninteraction with antipyrine, diazepam, and lorazepam.
    Abernethy DR, Greenblatt DJ, Eshelman FN, Shader RI.
    Clin Pharmacol Ther; 1984 Feb; 35(2):188-92. PubMed ID: 6319067
    [Abstract] [Full Text] [Related]

  • 48. Inhibition of ciramadol glucuronidation by benzodiazepines.
    Meacham RH, Sisenwine SF, Liu AL, Kick CJ, Barinov I, Ruelius HW.
    Drug Metab Dispos; 1986 Feb; 14(4):430-6. PubMed ID: 2873990
    [Abstract] [Full Text] [Related]

  • 49. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V.
    J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790
    [Abstract] [Full Text] [Related]

  • 50. Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam.
    Jochemsen R, van der Graaff M, Boeijinga JK, Breimer DD.
    Br J Clin Pharmacol; 1982 Mar; 13(3):319-24. PubMed ID: 7059433
    [Abstract] [Full Text] [Related]

  • 51. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Mar; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 52. Metoprolol pharmacokinetics and the oral contraceptive pill.
    Kendall MJ, Quarterman CP, Jack DB, Beeley L.
    Br J Clin Pharmacol; 1982 Jul; 14(1):120-2. PubMed ID: 7104164
    [Abstract] [Full Text] [Related]

  • 53. Simplified determination of lorazepam and oxazepam in biological fluids by gas chromatography-mass spectrometry.
    Higuchi S, Urabe H, Shiobara Y.
    J Chromatogr; 1979 Sep 11; 164(1):55-61. PubMed ID: 44299
    [Abstract] [Full Text] [Related]

  • 54. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ, Comer WH, Elliott HW, Shader RI, Knowles JA, Ruelius HW.
    J Clin Pharmacol; 1977 Sep 11; 17(8-9):490-4. PubMed ID: 19508
    [Abstract] [Full Text] [Related]

  • 55. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam.
    Greenblatt DJ, Divoll M, Harmatz JS, Shader RI.
    J Pharm Sci; 1982 Feb 11; 71(2):248-52. PubMed ID: 6121043
    [Abstract] [Full Text] [Related]

  • 56. Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives.
    Legler UF, Benet LZ.
    Clin Pharmacol Ther; 1986 Apr 11; 39(4):425-9. PubMed ID: 3956058
    [Abstract] [Full Text] [Related]

  • 57. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ, Grimmer SF, Rogers SM, Back DJ, Orme ML, Hodson ME, Batten JC.
    Thorax; 1987 Jan 11; 42(1):59-64. PubMed ID: 3112991
    [Abstract] [Full Text] [Related]

  • 58. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec 11; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 59. Kinetics of oxazepam and lorazepam in two subjects with Gilbert syndrome.
    Shader RI, Divoll M, Greenblatt DJ.
    J Clin Psychopharmacol; 1981 Nov 11; 1(6):400-2. PubMed ID: 6120963
    [No Abstract] [Full Text] [Related]

  • 60. Increased metabolic clearance of acetaminophen with oral contraceptive use.
    Abernethy DR, Divoll M, Ochs HR, Ameer B, Greenblatt DJ.
    Obstet Gynecol; 1982 Sep 11; 60(3):338-41. PubMed ID: 6897933
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.